Literature DB >> 1625744

Pneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis.

M B Smith, S B Hanauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1625744

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease.

Authors:  A Scalzini; C Barni; R Stellini; L Sueri
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

3.  Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease.

Authors:  Millie D Long; Francis A Farraye; Philip N Okafor; Christopher Martin; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2013-04       Impact factor: 5.325

4.  Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.

Authors:  Sally J Lawrence; Manish Sadarangani; Kevan Jacobson
Journal:  Front Pediatr       Date:  2017-07-24       Impact factor: 3.418

Review 5.  A Rare Case of Ulcerative Colitis with Severe Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis: A Case Report and Literature Review.

Authors:  Yusuke Watanabe; Kazunao Hayashi; Shuji Terai
Journal:  Intern Med       Date:  2021-08-06       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.